» Hepatitis Delta: a serious viral infection unknown in France MyPharma Editions

» Hepatitis Delta: a serious viral infection unknown in France MyPharma Editions

Posted on Wednesday 22nd June 2022 At the EASL (European Association for the Study of the Liver) Congress, June 22-26, Gilead Sciences is presenting the latest clinical data from the MYR301 therapy study and the results of a real-life study involving a French cohort treating hepatitis delta. Infection with the hepatitis delta virus (HDV) is … Read more